Alcohol Dependence Clinical Trial
Official title:
A Therapeutic Workplace for Alcohol Dependence
The purpose of this study is to determine whether the Therapeutic Workplace is effective in increasing and maintaining long-term drug abstinence in homeless, alcohol dependent adults.
Few populations are beset with the constellation of economic, social and health problems
that afflict homeless individuals. At the heart of much of this misfortune are staggering
rates of alcoholism and drug addiction. While it is not clear whether substance abuse is a
cause, consequence, or simply a correlate of homelessness, there is no question that
substance abuse is among the most common and most serious problems facing the homeless.
Given their unique set of serious and chronic problems, the Institute of Medicine has
identified the homeless as a group of people in need of specialized substance abuse
interventions. Prior research has shown that the Therapeutic Workplace intervention is
effective in the treatment of chronically unemployed heroin and cocaine dependent
individuals. The intervention integrates abstinence reinforcement contingencies of proven
efficacy into a model supported work program. Under this intervention, patients are paid to
perform data entry jobs in the Therapeutic Workplace. Those lacking needed skills are given
intensive training in basic academic and job skills. To reinforce abstinence from alcohol
and drugs, patients are required to provide an alcohol-free breath sample and drug-free
urine sample to gain entrance to the workplace each day. In this way, patients can work and
earn salary only when they abstain from alcohol and drugs. Patients are paid in vouchers
instead of cash to reduce the chance they will use their earnings to purchase alcohol or
drugs.
A randomized trial was conducted to evaluate the efficacy of this intervention in homeless,
alcohol-dependent adults who completed an inpatient alcohol detoxification. After the
detoxification, 124 participants were invited to attend the workplace for 6 months. They
were randomly assigned to one of three groups that differed in the requirements for voucher
reinforcement. One group received the full therapeutic workplace intervention in which
vouchers were contingent on both abstinence and work (Abstinence and Work group). A second
group was paid for work, but did not have to provide an alcohol-free breath sample or
drug-free urine sample to gain access to the workplace; their vouchers were contingent on
work only (Work-Only group). A third group was invited to attend the therapeutic workplace
but received no vouchers for work performed or abstinence achieved during treatment (No
Voucher group).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |